Construction and application of adenovirus-associated viral vector of CRISPR / Cas9 endonuclease system
A viral vector, virus technology, applied in the field of genes, can solve the problems of less expression and insertion mutation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0109] The construction of the AAV expression plasmid of embodiment 1, Cas9
[0110] The key element ITR of AAV expression vector (pAAV-MCS) is retained, and the middle sequence of ITR is replaced by CMV promoter and minipolyA site. Obtain 3×Flag-NLS-Cas9-NLS sequence from pX330 vector and insert it between CMV and minipolyA sites to obtain AAV-Cas9, in which the ITR intermediate sequence is 5.0kb in total, and the schematic diagram of its main components is as follows figure 1 A, designed so that AAV package size constraints can be met.
[0111] Construct the corresponding sgRNA expression vector Insert the chimeric RNA expression element in pX330 into the AAV expression vector (pAAV-MCS) and replace the ITR intermediate sequence to obtain AAV9-sgRNA. The schematic diagram of the main elements is as follows figure 1 b.
Embodiment 2
[0112] Example 2, Cas9 was successfully packaged into AAV9 adeno-associated virus and successfully expressed in mice
[0113] The constructed AAV expression vector of Cas9 (AAV-Cas9) was packaged into AAV9 adeno-associated virus, and intracardiacly injected into neonatal mice (within one week). One month later, different tissues of the mice were harvested, and the expression of Cas9 protein was detected by western blot after homogenization.
[0114] The result is as figure 2 As shown, Cas9 expression was highest in the heart, followed by brain and muscle. Other tissues expressed very low or undetectable.
Embodiment 3
[0115] Example 3. The Cas9 protein expressed through AAV9 can edit the DNA of cardiomyocytes under the combined action of sgRNA and tracrRNA
[0116] AAV9 adeno-associated virus expressing Cas9 and sgRNA chimeric RNA was injected into the left ventricle of neonatal mice, and genomic DNA of mouse myocardium was extracted one month later. The sequence of the DNA segment is detected by amplifying the DNA segment targeted by the sgRNA for sequencing. At the same time, Surveyor nucleic acid mismatch enzyme was used to detect the ratio of mutations in DNA.
[0117] The result is as image 3 As shown in A-B, mice injected with AAV9 virus expressing Cas9 and sgRNA had mutations in the target DNA of the myocardial genome, and these were insertion or deletion mutations. Mutation efficiency was then tested using Surveyor mismatch endonuclease. Genomic target DNA fragments are amplified using PCR and subjected to denaturation and reannealing slowly and uniformly, at which point wild-ty...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com